Michael E Jones Selected Research

Michael E Jones Research Topics

Disease

24	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2005
19	Neoplasms (Cancer) 04/2022 - 04/2003
3	Keloid 05/2019 - 07/2016
2	Carcinoma (Carcinomatosis) 04/2022 - 01/2022
2	Obesity 10/2021 - 01/2018
2	Wounds and Injuries (Trauma) 03/2021 - 09/2017
2	Infections 08/2020 - 11/2009
2	Cicatrix (Scar) 05/2019 - 07/2016
2	Communicable Diseases (Infectious Diseases) 11/2016 - 09/2011
2	Adenocarcinoma 07/2015 - 03/2005
2	Hypersensitivity (Allergy) 01/2013 - 09/2011
2	Endometrial Neoplasms (Endometrial Cancer) 06/2012 - 03/2005
2	Malaria 11/2011 - 11/2009
2	Liver Diseases (Liver Disease) 04/2003 - 02/2003
1	Turcot syndrome 01/2022
1	Endometriosis 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Abdominal Obesity 10/2021
1	Hepatitis B 08/2020
1	Genetic Risk Score 01/2020
1	Chromosome Fragility 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Carcinogenesis 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Birth Weight (Birth Weights) 10/2018
1	Hyperemesis Gravidarum 01/2018
1	Pre-Eclampsia (Preeclampsia) 01/2018
1	Pregnancy Complications 01/2018
1	Familial Breast Cancer 11/2017
1	Barrett Esophagus (Barrett's Esophagus) 07/2015
1	Japanese Encephalitis 01/2013
1	Anaphylaxis (Anaphylactic Shock) 09/2011
1	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2009
1	Liver Neoplasms (Liver Cancer) 04/2003
1	Nose Neoplasms 04/2003
1	Hepatocellular Carcinoma (Hepatoma) 02/2003

Drug/Important Bio-Agent (IBA)

7	Estrogen ReceptorsIBA 01/2022 - 11/2018
6	Hormones (Hormone)IBA 01/2022 - 05/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 11/2018
4	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 07/2013
3	Estrogens (Estrogen)FDA Link 10/2021 - 01/2019
3	VaccinesIBA 08/2020 - 09/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2009
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2019
2	mahuang-tangIBA 01/2022 - 01/2016
2	human ERBB2 proteinIBA 01/2022 - 01/2020
2	Testosterone (Sustanon)FDA Link 10/2021 - 07/2013
2	A-Form DNA (A-DNA)IBA 01/2019 - 01/2019
2	Biological ProductsIBA 01/2019 - 11/2017
2	Tamoxifen FDA LinkGeneric 06/2012 - 03/2005
1	taxaneIBA 04/2022
1	PlatinumIBA 04/2022
1	InterleukinsIBA 01/2022
1	ChromatinIBA 01/2022
1	Aromatase (CYP19)IBA 10/2021
1	NexusIBA 03/2021
1	Progesterone FDA LinkGeneric 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	CollagenIBA 05/2019
1	MelatoninIBA 01/2019
1	hydroxide ionIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	diepoxybutaneIBA 01/2019
1	olaparibIBA 01/2019
1	hydrogen sulfite (bisulfite)IBA 01/2019
1	Insulin-Like PeptidesIBA 10/2018
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 11/2017
1	Pharmaceutical PreparationsIBA 11/2016
1	Triamcinolone (Aristocort)FDA Link 07/2016
1	Progestins (Progestagens)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 07/2015
1	Cytochrome P-450 CYP3AIBA 05/2014
1	GlucuronidesIBA 05/2014
1	Estrone FDA Link 05/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2013
1	Japanese Encephalitis VaccinesIBA 01/2013
1	antineoplaston A10 (A 10)IBA 09/2011
1	Proguanil (Paludrine)FDA Link 11/2009
1	2- amino- 3- cyano- 6- methyl- 5- (4- pyridyl)pyridineIBA 11/2009
1	Doxycycline (Periostat)FDA LinkGeneric 11/2009
1	Mefloquine (Lariam)FDA LinkGeneric 11/2009
1	Atovaquone (Mepron)FDA Link 11/2009
1	Thorium Dioxide (Thorotrast)IBA 04/2003
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2003

Therapy/Procedure

5	Therapeutics 01/2022 - 06/2012
3	Radiotherapy 05/2019 - 07/2016
2	Chemoprevention 11/2011 - 11/2009
1	Drug Therapy (Chemotherapy) 04/2022
1	Neoadjuvant Therapy 04/2022
1	Body Piercing (Piercing, Body) 09/2017
1	Injections 07/2016
1	Duration of Therapy 03/2005